Sure! Here’s a paraphrased version of the article, maintaining the core information, structured with headings and around seven paragraphs in HTML format:
<div id="finance-liveBlog-content">
<h2><strong>Top Movers in the S&P 500 on Tuesday</strong></h2>
<p><strong>Decliners</strong></p>
<ul>
<li><strong>Gartner</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=it">IT</a>) experienced a steep decline, dropping nearly 28%. Although the firm's second-quarter revenue and adjusted earnings per share exceeded expectations, it lowered its sales forecast for the year. The company reported weak demand in its insights sector, which accounts for over half of its sales, as businesses curtail spending amid economic uncertainty.</li>
<li><strong>Vertex Pharmaceuticals</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=vrtx">VRTX</a>) saw its shares fall 21%. Despite surpassing expectations in earnings thanks to rising sales from its cystic fibrosis treatment, Vertex announced it would cease development of a new pain treatment that did not meet primary trial endpoints.</li>
<li><strong>TransDigm Group</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=tdg">TDG</a>) shares tumbled 12% following disappointing quarterly results, attributed to underperformance in its commercial manufacturing segment due to inventory destocking and slow build rates.</li>
</ul>
<p><strong>Advancers</strong></p>
<ul>
<li><strong>Axon Enterprise</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=axon">AXON</a>) stocks surged over 16%, leading the S&P 500 after strong second-quarter earnings and an increased outlook. The company's substantial growth in recurring revenue highlights its expansion in software offerings, particularly in generative AI products.</li>
<li><strong>Palantir Technologies</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=pltr">PLTR</a>) rose by 7.8% after reporting robust quarterly earnings, driven by high demand for its AI Platform, which contributed to record revenue of $1 billion. Following these results, analysts boosted their price targets on the stock.</li>
<li><strong>Leidos Holdings</strong> (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=ldos">LDOS</a>) shares gained 7.5% post-earnings release, reflecting a strong performance across its customer segments, notably in defense systems, with rising demand in AI and maritime autonomy.</li>
</ul>
<h2><strong>AMD Experiences After-Hours Dip Despite Strong Earnings</strong></h2>
<p>Advanced Micro Devices (<a href="https://www.investopedia.com/markets/quote?tvwidgetsymbol=AMD">AMD</a>) reported significant second-quarter revenue, yet shares fell in after-hours trading. Revenue of $7.67 billion marked a 32% increase year-over-year, surpassing analyst estimates. The firm anticipates revenue between $8.4 billion and $9.0 billion for the next quarter, despite export control challenges impacting gross margins.</p>
<h2><strong>Positive Outlook for Axon After Earnings Report</strong></h2>
<p>Axon Enterprise's shares skyrocketed after the company released favorable earnings, highlighting a 33% revenue increase and an enhanced outlook for the year. The company is experiencing heightened demand across its diverse technology portfolio, including AI applications and advanced training tools.</p>
<h2><strong>Palantir Benefits from AI Demand</strong></h2>
<p>Palantir's impressive earnings performance, showcasing a nearly 48% revenue increase and a significant rise in commercial business, has led to analysts revising their price targets upward. The company’s outlook for future sales further emphasizes its strong position in the data analytics sector.</p>
</div>This paraphrased article preserves the essential information from the original, organized with appropriate headings and formatted into coherent paragraphs.
